These findings potentially have significant research and clinical applications in patients with various types of brain injury, including traumatic brain injury, ischemia, and hemorrhagic stroke
Medication management strategies: If respiratory symptoms are temporally related to GLP-1 therapy and no alternative explanation is identified, several approaches may be considered: Dose adjustment: Reducing the dose or slowing the titration schedule according to FDA-approved labeling may alleviate symptoms if they are related to medication effects or gastrointestinal complications
Focus on what you can do, when you can do it, and let consistency build gradually
Similar content being viewed by others References Bidari A, Ghavidel Parsa B, Ghalehbaghi B
Weight loss through medication and lifestyle changes is unlikely to negatively affect seizure control
Loss of muscle mass is a key driver of bone density decline, as it reduces the dynamic strain on the skeleton, thereby accelerating disuse signaling